COVID-19 Clinical Features and Outcome in Italian Patients Treated with Biological Drugs Targeting Type 2 Inflammation

COVID-19 Clinical Features and Outcome in Italian Patients Treated with Biological Drugs Targeting Type 2 Inflammation

This is a multicentric investigation involving two Italian centers that examined the clinical course of COVID-19 in patients receiving biological therapy targeting type 2 inflammation and those not receiving biologicals. Since the beginning of the COVID-19 pandemic, the management of respiratory and...

Full description

Bibliographic Details
Main Authors: Giada Sambugaro, Elena Brambilla, Giulia Costanzo, Vera Bonato, Andrea Giovanni Ledda, Stefano Del Giacco, Riccardo Scarpa, Marcello Rattazzi, Elisabetta Favero, Francesco Cinetto, Davide Firinu
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Life
Subjects:
COVID-19
type 2 inflammation
biologicals
asthma
Online Access:https://www.mdpi.com/2075-1729/14/3/378

Internet

https://www.mdpi.com/2075-1729/14/3/378

Similar Items